Naltrexone

CHEMBL19019 Phase 4 承認済み Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
341.4 g/mol
LogP
1.9
Phase
4

This medication is used to help people who have stopped using opioids or alcohol from returning to these substances by blocking the pleasurable effects they would normally produce. It is taken daily as a tablet or given monthly as an injectable and works best as part of a comprehensive addiction treatment program.

分子量

341.4000 g/mol

LogP

1.90

TPSA

70.00 Ų

リピンスキーの五則

適合

治療領域

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D構造

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

O=C1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3CC2CC2)[C@H]1O5

InChI

InChI=1S/C20H23NO4/c22-13-4-3-12-9-15-20(24)6-5-14(23)18-19(20,16(12)17(13)25-18)7-8-21(15)10-11-1-2-11/h3-4,11,15,18,22,24H,1-2,5-10H2/t15-,18+,19+,20-/m1/s1

Molecular Formula

C20H23NO4

HBD / HBA

2 / 5

回転可能結合数

2

重原子数

25

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

よくある質問

This medication is used to help people who have stopped using opioids or alcohol from returning to these substances by blocking the pleasurable effects they would normally produce. It is taken daily as a tablet or given monthly as an injectable and works best as part of a comprehensive addiction treatment program.

Yes, Naltrexone is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL19019. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 5360515. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

医学的免責事項

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.